Hodgkin’s lymphoma in a patient on adalimumab treatment for psoriasis

Adalimumab is a human monoclonal antibody which targets tumor necrosis factor (TNF)-alpha. It is produced by recombinant DNA technology, using a mammalian cell expression system and is widely-known to treat a number of immune-mediated conditions, including psoriasis. There has been a growing concern...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:AME Case Rep
Main Authors: Alballa, Nouf, Alyousef, Alanoud, Alamari, Albatool, Alhumidi, Ahmed Abdullah, Zayed, Mohammed Ayesh, Zeitouni, Leena, Alsaif, Fahad Mohammed
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2018
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6327155/
https://ncbi.nlm.nih.gov/pubmed/30701218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/acr.2018.12.01
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados